47 results on '"Ye, Haige"'
Search Results
2. Lipase-triggered drug release from BCL2 inhibitor ABT-199-loaded nanoparticles to elevate anti-leukemic activity through enhanced drug targeting on the mitochondrial membrane
3. Progress in understanding the mechanisms of resistance to BCL-2 inhibitors
4. Treatment patterns, clinical outcomes and gene mutation characteristics of hepatitis B virus‐associated mantle cell lymphoma
5. Opportunities and challenges for anti-CD47 antibodies in hematological malignancies
6. Iron overload adversely effects bone marrow haematogenesis via SIRT-SOD2-mROS in a process ameliorated by curcumin
7. Progress in molecular feature of smoldering mantle cell lymphoma
8. The mechanism of SP1/p300 complex promotes proliferation of multiple myeloma cells through regulating IQGAP1 transcription
9. A regulatory circuitry between miR-193a/miR-600 and WT1 enhances leukemogenesis in acute myeloid leukemia
10. WT1 facilitates the self-renewal of leukemia-initiating cells through the upregulation of BCL2L2: WT1-BCL2L2 axis as a new acute myeloid leukemia therapy target
11. Treatment patterns and clinical outcomes of mantle cell lymphoma: A retrospective cohort study by CHOICE
12. DNA hypermethylation-induced miR-182 silence targets BCL2 and HOXA9 to facilitate the self-renewal of leukemia stem cell, accelerate acute myeloid leukemia progression, and determine the sensitivity of BCL2 inhibitor venetoclax
13. BTK Inhibitors in Combination with Rituximab and Lenalidomide (BTKiR2) for Elderly Patients with Newly Diagnosed Diffuse Large B Cell Lymphoma: A Single-Center Prospective Study in China
14. B Lymphocyte Chemoattractant (CXCL13) Is an Indicator of Acute Gastrointestinal GVHD in Murine Model
15. Paramount therapy for young and fit patients with mantle cell lymphoma: strategies for front-line therapy
16. Spontaneous regression of mantle cell lymphoma: a report of four cases
17. Pneumocystis jirovecii pneumonia in non-Hodgkin’s lymphoma after rituximab-based chemotherapy: a case series
18. Honokiol induces proteasomal degradation of AML1-ETO oncoprotein via increasing ubiquitin conjugase UbcH8 expression in leukemia
19. Therapeutic options and clinical outcomes of 1261 patients with mantle cell lymphoma in China ： a real-world retrospective multicenter analysis from Chinese Hematologist and Oncologist Innovation Cooperation of the excellent (CHOICE)
20. Dual targeting of PI3K and BCL‐2 overcomes ibrutinib resistance in aggressive mantle cell lymphoma
21. Plasma level of lipopolysaccharide-binding protein is indicative of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation
22. A proteomic approach for plasma biomarker discovery with 8-plex iTRAQ labeling and SCX-LC-MS/MS
23. MPO is a potential biomarker of acute graft-versus-host disease
24. Clinical and Cytogenetical Characteristics-Related Nomograms for Assessing Outcome of Acute Myeloid Leukemia Patients Post IA Induction
25. Iron Overload Adversely Effects Bone Marrow Haematogenesis via SIRT-SOD2-MROS in a Process Ameliorated by Curcumin
26. Prognostic value of hypoalbuminemia at diagnosis in de novo non-M3 acute myeloid leukemia
27. Targeting miR‐193a‐AML1‐ETO‐β‐catenin axis by melatonin suppresses the self‐renewal of leukaemia stem cells in leukaemia with t (8;21) translocation
28. Challenges and Opportunities for High-grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangement (Double-hit Lymphoma)
29. Simultaneous Inhibition of BCL-2 and PI3K Signaling Overcomes Ibrutinib Resistance in Mantle Cell Lymphoma
30. Prognostic value of hypoalbuminemia at diagnosis in de novo non-M3 acute myeloid leukemia.
31. Frontline Treatment for Older Patients with Mantle Cell Lymphoma
32. Prognostic significance of the red blood cell distribution width that maintain at high level following completion of first line therapy in mutiple myeloma patients
33. Plasma vascular non-inflammatory molecule 3 is associated with gastrointestinal acute graft-versus-host disease in mice
34. Smoldering mantle cell lymphoma
35. Erratum to: Plasma level of lipopolysaccharide-binding protein is indicative of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation
36. Phase II Study of Bortezomib in Combination with Cyclophosphamide and Rituximab for Relapsed or Refractory Mantle Cell Lymphoma
37. Novel chemotherapy‐free combination regimen for ibrutinib‐resistant mantle cell lymphoma
38. Lycorine induces cell death in MM by suppressing Janus Kinase/signal transducer and activator of transcription via inducing the expression of SOCS1
39. Effect of initial absolute monocyte count on survival outcome of patients with de novo non-M3 acute myeloid leukemia
40. Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase 2-producing K. pneumoniae at a Hematology Department in Wenzhou, China
41. Novel chemotherapy-free combination regimen for ibrutinib-resistant mantle cell lymphoma.
42. Quercetin suppresses the proliferation of multiple myeloma cells by down-regulating IQ motif-containing GTPase activating protein 1 expression and extracellular signal-regulated kinase activation
43. IQGAP1 plays an important role in the cell proliferation of multiple myeloma via the MAP kinase (ERK) pathway
44. Characterization of CD3+CD4−CD8− (double negative) T cells reconstitution in patients following hematopoietic stem-cell transplantation
45. Comment on “Transfusion of sickle cells may be a therapeutic option for patients suffering metastatic disease”
46. MLL2 protein is a prognostic marker for gastrointestinal diffuse large B-cell lymphoma.
47. Characterization of CD3+CD4-CD8- (double negative) T cells reconstitution in patients following hematopoietic stem-cell transplantation.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.